LAWRENCE PARSONS: Open Payments
NPI 1972021244 · EAST HAMPTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,279 in 141 payments from 23 companies in 2025. Trend: 2023 $2,255 · 2024 $2,399 · 2025 $3,279
Food & beverage: $3,279
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $501 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 22 | $441 |
| Ardelyx, Inc. | 13 | $322 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $294 |
| Janssen Biotech, Inc. | 11 | $271 |
| Madrigal Pharmaceuticals | 7 | $251 |
| Phathom Pharmaceuticals, Inc. | 10 | $246 |
| Gilead Sciences, Inc. | 9 | $169 |
| Exact Sciences Corporation | 5 | $145 |
| PFIZER INC. | 6 | $107 |
Products named: XIFAXAN, IBSRELA, TREMFYA, REZDIFFRA, VOQUEZNA, RINVOQ, ENTYVIO, SKYRIZI.
Industry payments across CT — which companies pay providers there.
